Santosh K Katiyar Selected Research

Santosh K Katiyar Research Topics

Disease

69	Neoplasms (Cancer) 12/2018 - 07/2002
23	Melanoma (Melanoma, Malignant) 10/2017 - 09/2003
23	Skin Neoplasms (Skin Cancer) 10/2017 - 07/2002
18	Neoplasm Metastasis (Metastasis) 12/2018 - 06/2004
15	Carcinogenesis 04/2014 - 09/2003
13	Inflammation (Inflammations) 10/2017 - 03/2007
11	Carcinoma (Carcinomatosis) 12/2018 - 04/2004
10	Contact Dermatitis (Eczema, Contact) 10/2017 - 12/2002
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018 - 02/2009
7	Skin Diseases (Skin Disease) 01/2011 - 09/2003
6	Squamous Cell Carcinoma of Head and Neck 11/2016 - 12/2011
6	Lung Neoplasms (Lung Cancer) 01/2016 - 01/2009
6	Breast Neoplasms (Breast Cancer) 03/2011 - 03/2004
5	Papilloma (Papillomatosis) 01/2016 - 07/2002
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2015 - 10/2006
4	Sunburn 01/2011 - 04/2006
4	Prostatic Neoplasms (Prostate Cancer) 05/2008 - 06/2004
3	Body Weight (Weight, Body) 01/2017 - 08/2015
3	Xeroderma Pigmentosum (Kaposi's Disease) 01/2011 - 04/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2013 - 01/2012
2	Infections 12/2012 - 10/2012

Drug/Important Bio-Agent (IBA)

23	Grape Seed ProanthocyanidinsIBA 12/2018 - 01/2005
20	TeaIBA 12/2018 - 07/2002
16	PhytochemicalsIBA 10/2017 - 03/2008
14	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2017 - 07/2002
14	Proteins (Proteins, Gene)FDA Link 02/2016 - 01/2005
12	Interleukin-12 (IL 12)IBA 12/2018 - 04/2006
12	Proanthocyanidins (Procyanidins)IBA 10/2017 - 08/2003
12	Biomarkers (Surrogate Marker)IBA 11/2015 - 09/2003
11	PolyphenolsIBA 12/2018 - 09/2003
10	SilymarinIBA 01/2016 - 12/2002
10	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 04/2004
10	CytokinesIBA 01/2014 - 04/2007
9	honokiolIBA 10/2017 - 11/2010
9	Caspase 3 (Caspase-3)IBA 01/2012 - 01/2005
9	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2010 - 03/2005
8	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 11/2003
8	ProstaglandinsIBA 04/2014 - 03/2009
7	CateninsIBA 02/2016 - 01/2011
7	Fibronectins (Fibronectin)IBA 01/2016 - 03/2006
7	Cadherins (E-Cadherin)IBA 01/2016 - 01/2011
7	CarcinogensIBA 12/2014 - 09/2003
6	Dinoprostone (PGE2)FDA Link 11/2017 - 01/2011
6	VimentinIBA 01/2016 - 01/2011
6	CyclinsIBA 11/2015 - 10/2006
6	Cyclin D1IBA 04/2014 - 04/2007
6	InterleukinsIBA 01/2014 - 05/2007
6	Pyrimidine DimersIBA 04/2011 - 09/2003
5	Anticarcinogenic AgentsIBA 10/2017 - 07/2002
5	AntioxidantsIBA 02/2016 - 07/2002
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 05/2009
5	BerberineIBA 01/2011 - 02/2006
5	Sunscreening Agents (Sunscreens)IBA 05/2010 - 12/2002
5	NF-kappa B (NF-kB)IBA 09/2009 - 04/2004
4	AlkaloidsIBA 01/2017 - 10/2006
4	Therapeutic UsesIBA 01/2017 - 12/2011
4	Mitogen-Activated Protein KinasesIBA 01/2014 - 04/2004
4	Interleukin-6 (Interleukin 6)IBA 01/2014 - 04/2007
4	Drinking WaterIBA 04/2011 - 03/2005
4	Prostaglandins EIBA 01/2011 - 03/2009
4	AndrogensIBA 05/2008 - 04/2004
3	DinitrofluorobenzeneIBA 07/2017 - 12/2002
3	Cell Cycle ProteinsIBA 11/2016 - 08/2015
3	ErbB Receptors (EGF Receptor)IBA 11/2016 - 08/2015
3	Small Interfering RNA (siRNA)IBA 02/2016 - 01/2011
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016 - 01/2011
3	FlavonoidsIBA 01/2016 - 01/2005
3	Apoptosis Regulatory ProteinsIBA 11/2015 - 01/2011
3	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 01/2015 - 01/2011
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2015 - 01/2013
3	Interleukin-17 (Interleukin 17)IBA 01/2015 - 03/2011
3	EchinocandinsIBA 01/2015 - 10/2012
3	Micafungin (FK463)FDA Link 01/2015 - 10/2012
3	Caspofungin (Cancidas)FDA Link 01/2015 - 10/2012
3	MethyltransferasesIBA 12/2014 - 11/2003
3	caffeic acid phenethyl esterIBA 01/2014 - 01/2011
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2011 - 07/2002
3	Messenger RNA (mRNA)IBA 12/2010 - 03/2004
3	EnzymesIBA 11/2010 - 07/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2007 - 09/2005
3	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 09/2005 - 04/2004
2	Insulin-Like PeptidesIBA 12/2018 - 02/2009
2	cryptolepineIBA 01/2017 - 12/2016
2	fisetinIBA 01/2016 - 01/2014
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2015 - 11/2010
2	CaspasesIBA 11/2015 - 02/2006
2	Catechin (Z 7300)IBA 01/2015 - 01/2011
2	Interleukin-17 ReceptorsIBA 01/2015 - 01/2012
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2014 - 11/2010
2	CollagenIBA 01/2014 - 03/2006
2	AzolesIBA 12/2012 - 10/2012
2	Desmoglein 2IBA 01/2012 - 01/2011
2	Histones (Histone)IBA 04/2011 - 04/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2011 - 03/2009
2	Celecoxib (Celebrex)FDA Link 01/2011 - 01/2011
2	isoquinolineIBA 01/2011 - 10/2006
2	ImmunosorbentsIBA 11/2010 - 11/2009

Therapy/Procedure

12	Therapeutics 11/2016 - 11/2003
8	Chemoprevention 12/2014 - 01/2005
5	Oral Administration 02/2016 - 12/2005